menu search

Beam therapeutics to participate in upcoming may investor conferences

CAMBRIDGE, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic ...

May 17, 2023, 6:30 am

Eli lilly (lly) stock up 18.7% ytd, new drugs key to growth

Lilly (LLY) expects to launch four new medicines by 2023 end, of which Mounjaro for type II diabetes an...

May 15, 2023, 12:09 pm

These 2 pharma stocks might face off soon -- but they could both win

Two new medicines are going to compete for the Alzheimer's therapy market. Eli Lilly's candidate appear...

May 14, 2023, 8:15 am

Pfizer ceo says medicare will likely face legal action over drug price negotiations

Pfizer CEO Albert Bourla argued the Biden administration's plan will cut profits and force Big Pharma companies to pull back on developing medicines....

May 11, 2023, 5:23 pm

Atyr pharma to present at the 2023 rbc capital markets global healthcare conference

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of fi...

May 11, 2023, 4:00 pm

Cancer immunotherapy market to reach usd 261.7 bn in 2031, expanding at a cagr of 13.6%: tmr report

The increasing prevalence of Cancer and increased adoption of targeted therapy over standard therapy is the key factor driving the global cancer immun...

May 11, 2023, 10:30 am

Beam therapeutics to participate in rbc capital markets 2023 global healthcare conference

CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic ...

May 11, 2023, 6:30 am

Catalyst pharmaceuticals advances snda submission plans to increase indicated maximum dose for firdapse® from 80 mg per day to 100 mg per day

Concluded Positive FDA Type-C Meeting in Early May 2023 Company On Track to Submit an sNDA Early in the Third Quarter of 2023 CORAL GABLES, Fla., May ...

May 9, 2023, 12:03 pm

Novartis ‘focusing on high-end, innovative medicines,' ceo says

Novartis CEO Vas Narasimhan joins Yahoo Finance Live anchors to discuss company earnings, focusing efforts on fighting cancer, consumer health, and cu...

May 9, 2023, 10:24 am

Fusion pharmaceuticals to present at the guggenheim healthcare talks radiopharmaceuticals day

HAMILTON, ON and BOSTON , May 9, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on develo...

May 9, 2023, 7:45 am

Nextcure to present at the jmp securities life sciences conference

BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering a...

May 9, 2023, 7:00 am

Blueprint is well-positioned to capitalize on ism market (maintain 'buy')

Blueprint medicines focuses on developing precision therapies for genomically defined cancers and blood...

May 9, 2023, 2:28 am

Revolution medicines, inc. (rvmd) q1 2023 earnings call transcript

Revolution Medicines, Inc. (NASDAQ:RVMD ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Erin Graves - Senior Director o...

May 8, 2023, 11:17 pm

Revolution medicines, inc. (rvmd) reports q1 loss, tops revenue estimates

Revolution Medicines, Inc. (RVMD) came out with a quarterly loss of $0.72 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compa...

May 8, 2023, 7:02 pm

Solid biosciences to present at jmp securities life sciences conference

CHARLESTOWN, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic ...

May 8, 2023, 4:05 pm

Benitec biopharma to present at the opmd international conference

HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene th...

May 8, 2023, 8:05 am

Deciphera pharmaceuticals to present at the jmp securities life sciences conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and c...

May 8, 2023, 7:00 am

Blueprint's (bpmc) q1 earnings & sales top estimates, view up

Blueprint medicines (BPMC) announces better-than-expected results for first-quarter 2023 as it beats es...

May 5, 2023, 8:23 am

4d molecular therapeutics announces pricing of upsized public offering of common stock

EMERYVILLE, Calif., May 04, 2023 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harness...

May 5, 2023, 1:04 am

Cyclacel pharmaceuticals to release first quarter 2023 financial results

BERKELEY HEIGHTS, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a ...

May 4, 2023, 9:15 am


Search within

Pages Search Results: